As advised via Pharmac Tender announcement 31 May 2018 there is to be a change in the listing and future sole supply.

New listing from 1 November 2018

Midazolam Mylan Inj 1 mg per ml, 5 ml 10 ampoule          Pharmacode 2474468                Schedule price $2.98

Midazolam Mylan Inj 5 mg per ml, 3 ml 5 ampoule            Pharmacode 2474476                Schedule price $2.36

Incumbent brand

Midazolam-Claris Inj 1 mg per ml 5ml 10                               Pharmacode 2503433          Schedule price $4.30

Midazolam-Claris Inj 5 mg per ml 3ml 5                                  Pharmacode 2471302          Schedule price $2.50

Reference pricing will apply not apply.

HML (Hospital Supply Status) commences 1 January 2019.

As of the date of this notification ProPharma / PWR cannot accept Midazolma-Claris for credit under any circumstances.

We would recommend you continue to purchase the incumbent and we will change automatically as existing stocks are exhausted.

Once again we need your support to ensure stock in the supply chain moves through, to effectively ensure no losses are incurred.

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.

About The Author